ACORN BIOVENTURES, L.P.
SEC insider (Form 3/4/5 filer). CIK 0001766853. 10% Owner at OnKure Therapeutics, Inc. (OKUR). 2 reported Form 4/5 transactions since Sep 2024; latest on May 15, 2025. Located in NEW YORK, NY.
Companies ACORN BIOVENTURES, L.P. has filed insider reports for
- OnKure Therapeutics, Inc. (OKUR): 10% Owner
ACORN BIOVENTURES, L.P.
CIK: 0001766853
Transaction Breakdown
Open Market Buys (P)2 (100.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)0 (0.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
OKUR
OnKure Therapeutics, Inc.
10% Owner